Anti-Integrin a2 [HAS-4] Invented by Prof Fiona Watt at Cancer Research UK London Research Institute: Lincoln's Inn Fields FACS IHC IF IP Antigen/Gene or Protein Targets: Integrin a2 (CD49b) 0 reviews 8 references 1 supplier
Anti-PLAP [HD 8B6] Invented by Prof Walter Bodmer at Cancer Research UK London Research Institute: Lincoln's Inn Fields ELISA IHC IF RIA Antigen/Gene or Protein Targets: Placental Alkaline Phosphatase (PLAP), Regan and Nagao isoenzymes. 0 reviews 8 references 1 supplier
Anti-PTPRC [HLe-1(2D1)] Invented by Prof Peter Beverley at Cancer Research UK London Research Institute: Lincoln's Inn Fields FACS IHC IF Antigen/Gene or Protein Targets: Protein tyrosine phosphatase, receptor type, C (PTPRC, CD45) 0 reviews 7 references 1 supplier
Anti-ICAM3 [ICAM 3.2] Invented at University of Oxford ELISA FACS IHC IF IP RIA WB Antigen/Gene or Protein Targets: ICAM3 (CD50) 0 reviews 8 references 1 supplier
Anti-Keratin7,13,17 & 18 [LdS 23] Invented at Cancer Research UK London Research Institute: Lincoln's Inn Fields IHC IF IP WB Antigen/Gene or Protein Targets: Keratin 7,13,17 & 18 0 reviews 2 references 1 supplier
Anti-HLADR [LHM 4] Invented at Queen Mary University of London IHC IP WB Antigen/Gene or Protein Targets: Human Leukocyte Antigen DR 0 reviews 2 references 1 supplier
Anti-Keratin 5/6/18 [LP34] Invented by Prof Birgit Lane at Cancer Research UK London Research Institute: Clare Hall Laboratories ELISA IHC IF WB Antigen/Gene or Protein Targets: Keratin 5/6/18 (pan-epithelial) 0 reviews 10 references 1 supplier
Anti-CD11c (Integrin aX) [3.9] Invented by Prof Nancy Hogg at Cancer Research UK London Research Institute: Lincoln's Inn Fields FACS IHC IF IP Fn Antigen/Gene or Protein Targets: Integrin alpha X (CD11c; gp150/95 a subunit) 0 reviews 28 references 1 supplier
Anti-HSVUL42 [2H4] Invented at Cancer Research UK London Research Institute: Clare Hall Laboratories ELISA IHC IF IP WB ICC Antigen/Gene or Protein Targets: Herpes Simplex Virus protein UL42 (HSV-UL42) 0 reviews 6 references 1 supplier
Anti-HLAD/DR, DQ [35] Invented by Prof Nancy Hogg at Cancer Research UK London Research Institute: Lincoln's Inn Fields FACS IHC IP Antigen/Gene or Protein Targets: Human Leukocyte Antigen (HLA) D/DR, DQ (MHC Class II) 0 reviews 2 references 1 supplier